Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.10M | 23.50M | 21.75M | 21.96M | 22.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.10M | 23.50M | 21.75M | 21.96M | 22.33M |
| Cost of Revenue | 6.58M | 6.19M | 5.76M | 6.25M | 6.78M |
| Gross Profit | 18.52M | 17.31M | 15.98M | 15.72M | 15.55M |
| SG&A Expenses | 17.25M | 20.25M | 23.18M | 25.62M | 28.25M |
| Depreciation & Amortization | 2.29M | 2.26M | 2.23M | 2.12M | 2.03M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.11M | 28.70M | 31.16M | 33.99M | 37.06M |
| Operating Income | -1.01M | -5.20M | -9.42M | -12.03M | -14.73M |
| Income Before Tax | -13.05M | -17.32M | -21.61M | -18.65M | -15.79M |
| Income Tax Expenses | 6.53M | 5.93M | 5.32M | 1.14M | -3.06M |
| Earnings from Continuing Operations | -19.58 | -23.24 | -26.93 | -19.79 | -12.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.58M | -23.24M | -26.93M | -19.79M | -12.74M |
| EBIT | -1.01M | -5.20M | -9.42M | -12.03M | -14.73M |
| EBITDA | 155.60K | -4.06M | -8.31M | -10.74M | -13.15M |
| EPS Basic | -0.23 | -0.27 | -0.31 | -0.23 | -0.15 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.08 | -0.10 | -0.12 |
| EPS Diluted | -0.23 | -0.27 | -0.31 | -0.23 | -0.15 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.08 | -0.10 | -0.12 |
| Average Basic Shares Outstanding | 387.35M | 366.28M | 345.22M | 345.19M | 345.15M |
| Average Diluted Shares Outstanding | 397.76M | 371.49M | 345.22M | 345.19M | 345.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |